Palisade Bio Plans 1-For-15 Reverse Split Of Its Common Stock
Portfolio Pulse from Benzinga Newsdesk
Palisade Bio announced a 1-for-15 reverse stock split effective April 8, 2024, to increase its per share price and comply with Nasdaq's minimum share price listing requirement. The stock will trade under the symbol 'PALI' with a new CUSIP number.

April 03, 2024 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Palisade Bio's 1-for-15 reverse stock split is set to increase its per share trading price to comply with Nasdaq's listing requirements.
Reverse stock splits are often used by companies to increase their share price to meet exchange listing requirements. While this does not fundamentally change the company's value, it can positively impact the stock's market perception and compliance status, potentially leading to a short-term positive price movement.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100